Index | Recent Threads | Unanswered Threads | Who's Active | Guidelines | Search |
![]() |
World Community Grid Forums
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
No member browsing this thread |
Thread Status: Active Total posts in this thread: 954
|
![]() |
Author |
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
Vaxon Biotech successfully completes its Phas... of Vx-001 cancer vaccine
Vaxon Biotech announced the successful conclusion of the Phase I/II trial of its Vx-001 therapeutic cancer vaccine. As a result, Vaxon is pursuing the clinical development of Vx-001 by launching a pivotal phase III trial in non-small cell lung cancer (NSCLC) in 2010, and in hepatocellular carcinoma and breast cancer in 2012-2013.... |
||
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
|
||
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
New Test Can Predict Return of Prostate Cancer
CHICAGO — A highly sensitive blood test may be able to predict whether prostate cancer is cured or is likely to come back, giving doctors an early sign of whether treatments are working, U.S. researchers said Wednesday. They said the nanotechnology-based blood test is far more sensitive than currently available commercial tests for prostate-specific antigen, or PSA, a protein produced by cells in the prostate gland..... |
||
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
CHICAGO (Reuters) - A third pivotal trial of ...red with current therapy.
CHICAGO (Reuters) - A third pivotal trial of Amgen Inc's denosumab found that it delayed by 21 percent the risk of fractures and other bone complications in men with advanced prostate cancer compared with current therapy. |
||
|
sk..
Master Cruncher http://s17.rimg.info/ccb5d62bd3e856cc0d1df9b0ee2f7f6a.gif Joined: Mar 22, 2007 Post Count: 2324 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
|
||
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
Drug boosts survival in major skin cancer study
Researchers have scored the first big win against melanoma, the deadliest form of skin cancer. An experimental drug significantly improved survival in a major study of people with very advanced disease. The results, reported Saturday at a cancer conference, left doctors elated. "We have not had any therapy that has prolonged survival" until now, said Dr. Lynn Schuchter of the Abramson Cancer Center at the University of Pennsylvania, a skin cancer specialist with no role in the study or ties to the drug's maker. The drug, ipilimumab, (ip-ee-LIM-uh-mab), works by helping the immune system fight tumors. The federal Food and Drug Administration has pledged a quick review, and doctors think the drug could be available by the end of this year.... |
||
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
Don't count on selenium to prevent lung cancer, suggests study
A new study has shown that taking the popular mineral supplement selenium doesn't reduce the likelihood of lung cancer recurrence.... |
||
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
|
||
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
|
||
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
Coffee cuts risk of head, neck cancers
Study: Down four cups a day and your risk is reduced by more than a third... |
||
|
|
![]() |